Halozyme Therapeutics | HALO - Pe Prix À Revenus

Prix De L'Action
62.76
Variation Quotidienne
-0.89 -1.40%
Mensuellement
-11.58%
Annuel
-2.43%
Q1 Prévisions
61.74




Pe Changement Date
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amarin 91.05 88.3 2023-06
Amgen 25.31 15.82 2025-12
Baxter International 17.1 4.46 2025-09
Cara Therapeutics 27.77 117.09 2021-09
Eli Lilly 40.21 9.66 2025-12
Esperion Therapeutics 129.79 129 2024-12
Halozyme Therapeutics 23.16 7.7 2025-12
Intrexon 7.54 221.44 2021-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
MannKind 303.7 273.14 2025-12
Pfizer 14.48 5.18 2025-12
Rigel Pharmaceuticals 8.61 8.4 2025-03
United Therapeutics 17.32 1.62 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06